Sort   by:  
 Page size 
UnknownPoly (ADP-ribose) polymerase inhibitors: recent advances and future development.
Not available
S-EPMC4517072 | biostudies-literature
UnknownFrequency of allogeneic hematopoietic cell transplantation among patients with high- or intermediate-risk acute myeloid leukemia in first complete remission.
Not available
S-EPMC3805928 | biostudies-literature
UnknownA SARS-CoV-2 vaccine candidate would likely match all currently circulating variants.
Not available
S-EPMC7519301 | biostudies-literature
UnknownSARS-CoV-2 recombinant spike ferritin nanoparticle vaccine adjuvanted with Army Liposome Formulation containing monophosphoryl lipid A and QS-21: a phase 1, randomised, double-blind, placebo-controlled, first-in-human clinical trial.
Not available
S-EPMC11192176 | biostudies-literature
UnknownMitoxantrone, etoposide and cytarabine following epigenetic priming with decitabine in adults with relapsed/refractory acute myeloid leukemia or other high-grade myeloid neoplasms: a phase 1/2 study.
Not available
S-EPMC5709258 | biostudies-literature
UnknownFeasibility, acceptability, and short-term impact of a brief sexually transmitted infection intervention targeting U.S. Military personnel and family members.
Not available
S-EPMC8977033 | biostudies-literature
UnknownMulti-omic spatial effects on high-resolution AI-derived retinal thickness.
Not available
S-EPMC11794613 | biostudies-literature
UnknownDevelopment of [211At]astatine-based anti-CD123 radioimmunotherapy for acute leukemias and other CD123+ malignancies.
Not available
S-EPMC9177726 | biostudies-literature
UnknownPhase 1/2 trial of GCLAM with dose-escalated mitoxantrone for newly diagnosed AML or other high-grade myeloid neoplasms.
Not available
S-EPMC6192860 | biostudies-literature
UnknownOutpatient intensive induction chemotherapy for acute myeloid leukemia and high-risk myelodysplastic syndrome.
Not available
S-EPMC7042997 | biostudies-literature
Sort   by:  
 Page size